GSK Plc plans to invest GBP 1bn (USD 1.2bn) over a decade to accelerate work on new medicines and vaccines to combat malaria, tuberculosis, HIV, neglected tropical diseases and antibiotic resistance.
The UK drugmaker said it has also formed a global health unit focused on the prevention and treatment of infectious diseases that disproportionately affect lower-income nations, an area that’s not usually profitable. The unit will have a “ring-fenced” budget, with results measured by health impact rather than financial returns, said Thomas Breuer, the company’s chief global health officer.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and partner Abbvie in the second half of this year.
Novo Nordisk denied general conditional reimbursement for Wegovy in Denmark – again
The Danish Medicines Agency has been told for the second time that the price of the obesity drug is not in line with the effect it provides.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Coloplast's climate goals approved by international initiative
The Science Based Targets initiative has approved Coloplast’s carbon emission reduction goals.
Top news from MedWatch this week
Miss anything?
Biomarker Operations Lead 
Commercial Market Data Manager 
KLIFO is looking for a Clinical Trial Assistant for our office in Glostrup, Lund or Münich 
Principal Scientist – Pharmacology 
Device Associate Director/Senior Project Leader 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Regulatory Affairs Manager - Maternity Cover 
Global Product Manager - ENT 
Chair of the Board 
Project Managers keep all of us healthy 
Director Regulatory Affairs 
Senior Teaching Fellow for the BioMedical Design Novo Nordisk Foundation Fellowship Program